Table of Contents

1 Market Overview

1.1 Spine Osteoarthritis Pain Drug Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Spine Osteoarthritis Pain Drug Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Oral

1.2.3 Injection

1.2.4 External

1.3 Market Analysis by Application

1.3.1 Overview: Global Spine Osteoarthritis Pain Drug Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Medical Care

1.3.3 Personal Care

1.4 Overview of Global Spine Osteoarthritis Pain Drug Market

1.4.1 Global Spine Osteoarthritis Pain Drug Market Status and Outlook (2015-2025)

1.4.2 North America (United States, Canada and Mexico)

1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.5 South America, Middle East & Africa

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Pfizer SWOT Analysis

2.1.4 Pfizer Product and Services

2.1.5 Pfizer Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 Horizon Pharma

2.2.1 Horizon Pharma Details

2.2.2 Horizon Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Horizon Pharma SWOT Analysis

2.2.4 Horizon Pharma Product and Services

2.2.5 Horizon Pharma Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 Bayer

2.3.1 Bayer Details

2.3.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Bayer SWOT Analysis

2.3.4 Bayer Product and Services

2.3.5 Bayer Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 Johnson and Johnson

2.4.1 Johnson and Johnson Details

2.4.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Johnson and Johnson SWOT Analysis

2.4.4 Johnson and Johnson Product and Services

2.4.5 Johnson and Johnson Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 Sanofi

2.5.1 Sanofi Details

2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Sanofi SWOT Analysis

2.5.4 Sanofi Product and Services

2.5.5 Sanofi Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 GlaxoSmithKline

2.6.1 GlaxoSmithKline Details

2.6.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 GlaxoSmithKline SWOT Analysis

2.6.4 GlaxoSmithKline Product and Services

2.6.5 GlaxoSmithKline Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 Mylan

2.7.1 Mylan Details

2.7.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Mylan SWOT Analysis

2.7.4 Mylan Product and Services

2.7.5 Mylan Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.8 Novartis

2.8.1 Novartis Details

2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Novartis SWOT Analysis

2.8.4 Novartis Product and Services

2.8.5 Novartis Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.9 Eli Lilly

2.9.1 Eli Lilly Details

2.9.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Eli Lilly SWOT Analysis

2.9.4 Eli Lilly Product and Services

2.9.5 Eli Lilly Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.10 Abbott

2.10.1 Abbott Details

2.10.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Abbott SWOT Analysis

2.10.4 Abbott Product and Services

2.10.5 Abbott Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.11 Tide Pharmaceutical

2.11.1 Tide Pharmaceutical Details

2.11.2 Tide Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Tide Pharmaceutical SWOT Analysis

2.11.4 Tide Pharmaceutical Product and Services

2.11.5 Tide Pharmaceutical Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.12 Abiogen Pharma

2.12.1 Abiogen Pharma Details

2.12.2 Abiogen Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 Abiogen Pharma SWOT Analysis

2.12.4 Abiogen Pharma Product and Services

2.12.5 Abiogen Pharma Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.13 Daiichi Sankyo

2.13.1 Daiichi Sankyo Details

2.13.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 Daiichi Sankyo SWOT Analysis

2.13.4 Daiichi Sankyo Product and Services

2.13.5 Daiichi Sankyo Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.14 Iroko Pharmaceuticals

2.14.1 Iroko Pharmaceuticals Details

2.14.2 Iroko Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis

2.14.3 Iroko Pharmaceuticals SWOT Analysis

2.14.4 Iroko Pharmaceuticals Product and Services

2.14.5 Iroko Pharmaceuticals Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.15 Astellas Pharma

2.15.1 Astellas Pharma Details

2.15.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.15.3 Astellas Pharma SWOT Analysis

2.15.4 Astellas Pharma Product and Services

2.15.5 Astellas Pharma Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.16 TEVA

2.16.1 TEVA Details

2.16.2 TEVA Major Business and Total Revenue (Financial Highlights) Analysis

2.16.3 TEVA SWOT Analysis

2.16.4 TEVA Product and Services

2.16.5 TEVA Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.17 Hengrui Pharmaceutical

2.17.1 Hengrui Pharmaceutical Details

2.17.2 Hengrui Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis

2.17.3 Hengrui Pharmaceutical SWOT Analysis

2.17.4 Hengrui Pharmaceutical Product and Services

2.17.5 Hengrui Pharmaceutical Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.18 Almatica Pharma

2.18.1 Almatica Pharma Details

2.18.2 Almatica Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.18.3 Almatica Pharma SWOT Analysis

2.18.4 Almatica Pharma Product and Services

2.18.5 Almatica Pharma Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Spine Osteoarthritis Pain Drug Sales and Market Share by Manufacturer (2018-2019)

3.2 Global Spine Osteoarthritis Pain Drug Revenue and Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Spine Osteoarthritis Pain Drug Manufacturer Market Share in 2019

3.3.2 Top 6 Spine Osteoarthritis Pain Drug Manufacturer Market Share in 2019

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Spine Osteoarthritis Pain Drug Sales, Revenue and Market Share by Regions

4.1.1 Global Spine Osteoarthritis Pain Drug Sales and Market Share by Regions (2015-2020)

4.1.2 Global Spine Osteoarthritis Pain Drug Revenue and Market Share by Regions (2015-2020)

4.2 North America Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

4.3 Europe Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

4.4 Asia-Pacific Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

4.5 South America Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

4.6 Middle East and Africa Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

5 North America by Country

5.1 North America Spine Osteoarthritis Pain Drug Sales, Revenue and Market Share by Country

5.1.1 North America Spine Osteoarthritis Pain Drug Sales and Market Share by Country (2015-2020)

5.1.2 North America Spine Osteoarthritis Pain Drug Revenue and Market Share by Country (2015-2020)

5.2 United States Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

5.3 Canada Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

5.4 Mexico Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

6 Europe by Country

6.1 Europe Spine Osteoarthritis Pain Drug Sales, Revenue and Market Share by Country

6.1.1 Europe Spine Osteoarthritis Pain Drug Sales and Market Share by Country (2015-2020)

6.1.2 Europe Spine Osteoarthritis Pain Drug Revenue and Market Share by Country (2015-2020)

6.2 Germany Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

6.3 UK Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

6.4 France Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

6.5 Russia Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

6.6 Italy Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Spine Osteoarthritis Pain Drug Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Spine Osteoarthritis Pain Drug Sales and Market Share by Regions (2015-2020)

7.1.2 Asia-Pacific Spine Osteoarthritis Pain Drug Revenue and Market Share by Regions (2015-2020)

7.2 China Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

7.3 Japan Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

7.4 Korea Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

7.5 India Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

7.6 Southeast Asia Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

7.7 Australia Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

8 South America by Country

8.1 South America Spine Osteoarthritis Pain Drug Sales, Revenue and Market Share by Country

8.1.1 South America Spine Osteoarthritis Pain Drug Sales and Market Share by Country (2015-2020)

8.1.2 South America Spine Osteoarthritis Pain Drug Revenue and Market Share by Country (2015-2020)

8.2 Brazil Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

8.3 Argentina Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Spine Osteoarthritis Pain Drug Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Spine Osteoarthritis Pain Drug Sales and Market Share by Country (2015-2020)

9.1.2 Middle East & Africa Spine Osteoarthritis Pain Drug Revenue and Market Share by Country (2015-2020)

9.2 Saudi Arabia Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

9.3 Turkey Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

9.4 Egypt Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

9.5 South Africa Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

10 Market Segment by Type

10.1 Global Spine Osteoarthritis Pain Drug Sales and Market Share by Type (2015-2020)

10.2 Global Spine Osteoarthritis Pain Drug Revenue and Market Share by Type (2015-2020)

10.3 Global Spine Osteoarthritis Pain Drug Price by Type (2015-2020)

11 Global Spine Osteoarthritis Pain Drug Market Segment by Application

11.1 Global Spine Osteoarthritis Pain Drug Sales Market Share by Application (2015-2020)

11.2 Global Spine Osteoarthritis Pain Drug Revenue Market Share by Application (2015-2020)

11.3 Global Spine Osteoarthritis Pain Drug Price by Application (2015-2020)

12 Market Forecast

12.1 Global Spine Osteoarthritis Pain Drug Sales, Revenue and Growth Rate (2021-2025)

12.2 Spine Osteoarthritis Pain Drug Market Forecast by Regions (2021-2025)

12.2.1 North America Spine Osteoarthritis Pain Drug Market Forecast (2021-2025)

12.2.2 Europe Spine Osteoarthritis Pain Drug Market Forecast (2021-2025)

12.2.3 Asia-Pacific Spine Osteoarthritis Pain Drug Market Forecast (2021-2025)

12.2.4 South America Spine Osteoarthritis Pain Drug Market Forecast (2021-2025)

12.2.5 Middle East & Africa Spine Osteoarthritis Pain Drug Market Forecast (2021-2025)

12.3 Spine Osteoarthritis Pain Drug Market Forecast by Type (2021-2025)

12.3.1 Global Spine Osteoarthritis Pain Drug Sales Forecast by Type (2021-2025)

12.3.2 Global Spine Osteoarthritis Pain Drug Market Share Forecast by Type (2021-2025)

12.4 Spine Osteoarthritis Pain Drug Market Forecast by Application (2021-2025)

12.4.1 Global Spine Osteoarthritis Pain Drug Sales Forecast by Application (2021-2025)

12.4.2 Global Spine Osteoarthritis Pain Drug Market Share Forecast by Application (2021-2025)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

15.3 Disclaimer

15.4 About US

List of Tables

Table 1. Global Spine Osteoarthritis Pain Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Spine Osteoarthritis Pain Drug by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Spine Osteoarthritis Pain Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Market Opportunities in Next Few Years

Table 5. Market Risks Analysis

Table 6. Market Drivers

Table 7. Pfizer Basic Information, Manufacturing Base and Competitors

Table 8. Pfizer Spine Osteoarthritis Pain Drug Major Business

Table 9. Pfizer Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 10. Pfizer SWOT Analysis

Table 11. Pfizer Spine Osteoarthritis Pain Drug Product and Services

Table 12. Pfizer Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 13. Horizon Pharma Basic Information, Manufacturing Base and Competitors

Table 14. Horizon Pharma Spine Osteoarthritis Pain Drug Major Business

Table 15. Horizon Pharma Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 16. Horizon Pharma SWOT Analysis

Table 17. Horizon Pharma Spine Osteoarthritis Pain Drug Product and Services

Table 18. Horizon Pharma Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 19. Bayer Basic Information, Manufacturing Base and Competitors

Table 20. Bayer Spine Osteoarthritis Pain Drug Major Business

Table 21. Bayer Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 22. Bayer SWOT Analysis

Table 23. Bayer Spine Osteoarthritis Pain Drug Product and Services

Table 24. Bayer Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 25. Johnson and Johnson Basic Information, Manufacturing Base and Competitors

Table 26. Johnson and Johnson Spine Osteoarthritis Pain Drug Major Business

Table 27. Johnson and Johnson Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 28. Johnson and Johnson SWOT Analysis

Table 29. Johnson and Johnson Spine Osteoarthritis Pain Drug Product and Services

Table 30. Johnson and Johnson Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 31. Sanofi Basic Information, Manufacturing Base and Competitors

Table 32. Sanofi Spine Osteoarthritis Pain Drug Major Business

Table 33. Sanofi Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 34. Sanofi SWOT Analysis

Table 35. Sanofi Spine Osteoarthritis Pain Drug Product and Services

Table 36. Sanofi Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 37. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table 38. GlaxoSmithKline Spine Osteoarthritis Pain Drug Major Business

Table 39. GlaxoSmithKline Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 40. GlaxoSmithKline SWOT Analysis

Table 41. GlaxoSmithKline Spine Osteoarthritis Pain Drug Product and Services

Table 42. GlaxoSmithKline Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 43. Mylan Basic Information, Manufacturing Base and Competitors

Table 44. Mylan Spine Osteoarthritis Pain Drug Major Business

Table 45. Mylan Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 46. Mylan SWOT Analysis

Table 47. Mylan Spine Osteoarthritis Pain Drug Product and Services

Table 48. Mylan Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 49. Novartis Basic Information, Manufacturing Base and Competitors

Table 50. Novartis Spine Osteoarthritis Pain Drug Major Business

Table 51. Novartis Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 52. Novartis SWOT Analysis

Table 53. Novartis Spine Osteoarthritis Pain Drug Product and Services

Table 54. Novartis Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 55. Eli Lilly Basic Information, Manufacturing Base and Competitors

Table 56. Eli Lilly Spine Osteoarthritis Pain Drug Major Business

Table 57. Eli Lilly Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 58. Eli Lilly SWOT Analysis

Table 59. Eli Lilly Spine Osteoarthritis Pain Drug Product and Services

Table 60. Eli Lilly Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 61. Abbott Basic Information, Manufacturing Base and Competitors

Table 62. Abbott Spine Osteoarthritis Pain Drug Major Business

Table 63. Abbott Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 64. Abbott SWOT Analysis

Table 65. Abbott Spine Osteoarthritis Pain Drug Product and Services

Table 66. Abbott Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 67. Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 68. Tide Pharmaceutical Spine Osteoarthritis Pain Drug Major Business

Table 69. Tide Pharmaceutical Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 70. Tide Pharmaceutical SWOT Analysis

Table 71. Tide Pharmaceutical Spine Osteoarthritis Pain Drug Product and Services

Table 72. Tide Pharmaceutical Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 73. Abiogen Pharma Basic Information, Manufacturing Base and Competitors

Table 74. Abiogen Pharma Spine Osteoarthritis Pain Drug Major Business

Table 75. Abiogen Pharma Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 76. Abiogen Pharma SWOT Analysis

Table 77. Abiogen Pharma Spine Osteoarthritis Pain Drug Product and Services

Table 78. Abiogen Pharma Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 79. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors

Table 80. Daiichi Sankyo Spine Osteoarthritis Pain Drug Major Business

Table 81. Daiichi Sankyo Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 82. Daiichi Sankyo SWOT Analysis

Table 83. Daiichi Sankyo Spine Osteoarthritis Pain Drug Product and Services

Table 84. Daiichi Sankyo Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 85. Iroko Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 86. Iroko Pharmaceuticals Spine Osteoarthritis Pain Drug Major Business

Table 87. Iroko Pharmaceuticals Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 88. Iroko Pharmaceuticals SWOT Analysis

Table 89. Iroko Pharmaceuticals Spine Osteoarthritis Pain Drug Product and Services

Table 90. Iroko Pharmaceuticals Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 91. Astellas Pharma Basic Information, Manufacturing Base and Competitors

Table 92. Astellas Pharma Spine Osteoarthritis Pain Drug Major Business

Table 93. Astellas Pharma Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 94. Astellas Pharma SWOT Analysis

Table 95. Astellas Pharma Spine Osteoarthritis Pain Drug Product and Services

Table 96. Astellas Pharma Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 97. TEVA Basic Information, Manufacturing Base and Competitors

Table 98. TEVA Spine Osteoarthritis Pain Drug Major Business

Table 99. TEVA Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 100. TEVA SWOT Analysis

Table 101. TEVA Spine Osteoarthritis Pain Drug Product and Services

Table 102. TEVA Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 103. Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 104. Hengrui Pharmaceutical Spine Osteoarthritis Pain Drug Major Business

Table 105. Hengrui Pharmaceutical Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 106. Hengrui Pharmaceutical SWOT Analysis

Table 107. Hengrui Pharmaceutical Spine Osteoarthritis Pain Drug Product and Services

Table 108. Hengrui Pharmaceutical Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 109. Almatica Pharma Spine Osteoarthritis Pain Drug Type and Application

Table 110. Almatica Pharma Spine Osteoarthritis Pain Drug Major Business

Table 111. Almatica Pharma Spine Osteoarthritis Pain Drug Total Revenue (USD Million) (2017-2018)

Table 112. Almatica Pharma SWOT Analysis

Table 113. Almatica Pharma Spine Osteoarthritis Pain Drug Product and Services

Table 114. Almatica Pharma Spine Osteoarthritis Pain Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 115. Global Spine Osteoarthritis Pain Drug Sales by Manufacturer (2018-2019) (K Units)

Table 116. Global Spine Osteoarthritis Pain Drug Revenue by Manufacturer (2018-2019) (USD Million)

Table 117. Global Spine Osteoarthritis Pain Drug Sales by Regions (2015-2020) (K Units)

Table 118. Global Spine Osteoarthritis Pain Drug Sales Market Share by Regions (2015-2020)

Table 119. Global Spine Osteoarthritis Pain Drug Revenue by Regions (2015-2020) (USD Million)

Table 120. North America Spine Osteoarthritis Pain Drug Sales by Countries (2015-2020) (K Units)

Table 121. North America Spine Osteoarthritis Pain Drug Sales Market Share by Countries (2015-2020)

Table 122. North America Spine Osteoarthritis Pain Drug Revenue by Countries (2015-2020) (USD Million)

Table 123. North America Spine Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020)

Table 124. Europe Spine Osteoarthritis Pain Drug Sales by Countries (2015-2020) (K Units)

Table 125. Europe Spine Osteoarthritis Pain Drug Sales Market Share by Countries (2015-2020)

Table 126. Europe Spine Osteoarthritis Pain Drug Revenue by Countries (2015-2020) (USD Million)

Table 127. Asia-Pacific Spine Osteoarthritis Pain Drug Sales by Regions (2015-2020) (K Units)

Table 128. Asia-Pacific Spine Osteoarthritis Pain Drug Sales Market Share by Regions (2015-2020)

Table 129. Asia-Pacific Spine Osteoarthritis Pain Drug Revenue by Regions (2015-2020) (USD Million)

Table 130. South America Spine Osteoarthritis Pain Drug Sales by Countries (2015-2020) (K Units)

Table 131. South America Spine Osteoarthritis Pain Drug Sales Market Share by Countries (2015-2020)

Table 132. South America Spine Osteoarthritis Pain Drug Revenue by Countries (2015-2020) (USD Million)

Table 133. South America Spine Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020)

Table 134. Middle East & Africa Spine Osteoarthritis Pain Drug Sales by Countries (2015-2020) (K Units)

Table 135. Middle East & Africa Spine Osteoarthritis Pain Drug Sales Market Share by Countries (2015-2020)

Table 136. Middle East & Africa Spine Osteoarthritis Pain Drug Revenue by Countries (2015-2020) (USD Million)

Table 137. Middle East & Africa Spine Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020)

Table 138. Global Spine Osteoarthritis Pain Drug Sales by Type (2015-2020) (K Units)

Table 139. Global Spine Osteoarthritis Pain Drug Sales Share by Type (2015-2020)

Table 140. Global Spine Osteoarthritis Pain Drug Revenue by Type (2015-2020) (USD Million)

Table 141. Global Spine Osteoarthritis Pain Drug Revenue Share by Type (2015-2020)

Table 142. Global Spine Osteoarthritis Pain Drug Sales by Application (2015-2020) (K Units)

Table 143. Global Spine Osteoarthritis Pain Drug Sales Share by Application (2015-2020)

Table 144. Global Spine Osteoarthritis Pain Drug Sales Forecast by Regions (2021-2025) (K Units)

Table 145. Global Spine Osteoarthritis Pain Drug Market Share Forecast by Regions (2021-2025)

Table 146. Global Spine Osteoarthritis Pain Drug Sales Forecast by Type (2021-2025) (K Units)

Table 147. Global Spine Osteoarthritis Pain Drug Market Share Forecast by Type (2021-2025)

Table 148. Global Spine Osteoarthritis Pain Drug Sales Forecast by Application (2021-2025)

Table 149. Global Spine Osteoarthritis Pain Drug Market Share Forecast by Application (2021-2025)

Table 150. Direct Channel Pros & Cons

Table 151. Indirect Channel Pros & Cons

Table 152. Distributors/Traders/ Dealers List

List of Figures

Figure 1. Spine Osteoarthritis Pain Drug Picture

Figure 2. Global Sales Market Share of Spine Osteoarthritis Pain Drug by Type in 2019

Figure 3. Oral Picture

Figure 4. Injection Picture

Figure 5. External Picture

Figure 6. Spine Osteoarthritis Pain Drug Sales Market Share by Application in 2018

Figure 7. Medical Care Picture

Figure 8. Personal Care Picture

Figure 9. Global Spine Osteoarthritis Pain Drug Market Status and Outlook (2015-2025) (USD Million)

Figure 10. United States Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 11. Canada Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 12. Mexico Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 13. Germany Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 14. France Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 15. UK Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 16. Russia Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 17. Italy Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 18. China Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 19. Japan Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 20. Korea Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 21. India Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 22. Southeast Asia Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 23. Australia Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)

Figure 24. Brazil Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 25. Egypt Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 26. Saudi Arabia Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 27. South Africa Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 28. Turkey Spine Osteoarthritis Pain Drug Revenue (Value) and Growth Rate (2015-2025)

Figure 29. Global Spine Osteoarthritis Pain Drug Sales Market Share by Manufacturer in 2019

Figure 30. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Manufacturer in 2019

Figure 31. Top 3 Spine Osteoarthritis Pain Drug Manufacturer (Revenue) Market Share in 2019

Figure 32. Top 6 Spine Osteoarthritis Pain Drug Manufacturer (Revenue) Market Share in 2019

Figure 33. Key Manufacturer Market Share Trend

Figure 34. Global Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 35. Global Spine Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 36. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Regions (2015-2020)

Figure 37. Global Spine Osteoarthritis Pain Drug Revenue Market Share by Regions in 2018

Figure 38. North America Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

Figure 39. Europe Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

Figure 40. Asia-Pacific Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

Figure 41. South America Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

Figure 42. Middle East & Africa Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020)

Figure 43. North America Spine Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 44. North America Spine Osteoarthritis Pain Drug Sales Market Share by Countries (2015-2020)

Figure 45. North America Spine Osteoarthritis Pain Drug Sales Market Share by Countries in 2018

Figure 46. North America Spine Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020) (USD Million)

Figure 47. North America Spine Osteoarthritis Pain Drug Revenue Market Share by Countries in 2018

Figure 48. United States Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 49. Canada Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 50. Mexico Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 51. Europe Spine Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 52. Europe Spine Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020)

Figure 53. Europe Spine Osteoarthritis Pain Drug Revenue Market Share by Countries in 2019

Figure 54. Germany Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 55. UK Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 56. France Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 57. Russia Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 58. Italy Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 59. Asia-Pacific Spine Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 60. Asia-Pacific Spine Osteoarthritis Pain Drug Sales Market Share by Regions 2019

Figure 61. Asia-Pacific Spine Osteoarthritis Pain Drug Revenue Market Share by Regions 2019

Figure 62. China Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 63. Japan Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 64. Korea Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 65. India Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 66. Southeast Asia Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 67. South America Spine Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 68. South America Spine Osteoarthritis Pain Drug Sales Market Share by Countries in 2019

Figure 69. South America Spine Osteoarthritis Pain Drug Revenue Market Share by Countries in 2019

Figure 70. Brazil Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 71. Argentina Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 72. Middle East and Africa Spine Osteoarthritis Pain Drug Revenue and Growth Rate (2015-2020) (USD Million)

Figure 73. Middle East and Africa Spine Osteoarthritis Pain Drug Sales Market Share by Countries in 2019

Figure 74. Middle East and Africa Spine Osteoarthritis Pain Drug Revenue Market Share by Countries (2015-2020)

Figure 75. Middle East and Africa Spine Osteoarthritis Pain Drug Revenue Market Share by Countries in 2019

Figure 76. Saudi Arabia Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 77. Egypt Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 78. Turkey Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 79. South Africa Spine Osteoarthritis Pain Drug Sales and Growth Rate (2015-2020) (K Units)

Figure 80. Global Spine Osteoarthritis Pain Drug Sales and Growth Rate (2021-2025) (K Units)

Figure 81. Global Spine Osteoarthritis Pain Drug Revenue and Growth Rate (2021-2025) (USD Million)

Figure 82. North America Sales Spine Osteoarthritis Pain Drug Market Forecast (2021-2025) (K Units)

Figure 83. Europe Sales Spine Osteoarthritis Pain Drug Market Forecast (2021-2025) (K Units)

Figure 84. Asia-Pacific Sales Spine Osteoarthritis Pain Drug Market Forecast (2021-2025) (K Units)

Figure 85. South America Sales Spine Osteoarthritis Pain Drug Market Forecast (2021-2025) (K Units)

Figure 86. Middle East & Africa Sales Spine Osteoarthritis Pain Drug Market Forecast (2021-2025) (K Units)

Figure 87. Sales Channel: Direct Channel vs Indirect Channel